MHMatthew K. Hysell

Matthew K. Hysell

*This is an algorithmically generated author record based on publicly available information.

Matthew K. Hysell has a total of 19 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Safety and Efficacy of External Nasal Dilator Strips with N95 Respirator Masks by Emergency Department Personnel

    by Ariel Hawley, Mitchell Rozman, Matthew Hysell

    INTRODUCTION: The coronavirus disease 2019 (COVID-19) pandemic has prompted increased use of personal protective equipment (PPE) to maintain the health and safety of caregivers. This study was conducted in 2020 to evaluate the safety and efficacy of external nasal dilator strips (ENDS) coupled with N95 respirators in a sample of community hospital emergency department personnel. METHODS: After obtaining written consent, the authors tested participants’ response to exercise (i.e., walking up 10 flights of stairs) while wearing an N95 respirator, both with and without an ENDS. The authors measured participants’ heart rate and respiratory effort responses over four minutes following their exercise trial. A convenience sample of these personnel also repeated their respirator fit testing while wearing an ENDS with the N95 style they had previously been fitted for. RESULTS: A total of N = 50 participants were enrolled. Peak heart rate while wearing an ENDS was 125 beats per minute (BPM) with the ENDS versus 130 BPM without (p = 0.21). The Borg Exertion Score while wearing an ENDS peaked at 13 with the ENDS versus 14 without (p = 0.08). However, when subjects were surveyed before and after the trial upon whether they would consider using an ENDS beneath their N95 using a scale of 1-5, their interest in this significantly increased (p = 0.004). Four of the 13 (31%) participants who completed repeated fit testing while wearing the ENDS beneath their N95 respirator failed the repeat testing. CONCLUSIONS: These results first suggest that a sizable proportion of ED personnel may fail N95 fit testing while wearing an ENDS beneath the N95 mask for which they had been previously fitted. Although providers’ subjective interest in use of ENDS increased, these results also demonstrate that use of an ENDS beneath an N95 respirator may not significantly increase exercise tolerance.


  • Open Access

    Legionella Pneumonia on Point-of-care Ultrasound in the Emergency Department: A Case Report

    by Robert W. Lopez, Matthew K. Hysell, Jereme P. Long, Joseph Longobardi

    Introduction:Legionella is an uncommon, atypical organism that can cause community-acquired pneumonia. Commonly associated with high fevers, gastrointestinal symptoms, and hyponatremia, it can be easily overlooked, especially during the coronavirus disease of 2019 (COVID-19) pandemic. Legionella has specific antibiotic treatment that will improve outcome; thus, its recognition is important.Case Report: We present a case of Legionella pneumonia in a man presenting with shortness of breath and fever. The patient’s initial chest radiography was negative. With the use of point-of-care ultrasound (POCUS) the changes of atypical pneumonia could be seen. Ultimately Legionella was confirmed with urine antigen testing, and appropriate antibiotic treatment was started.Discussion: Given the increased awareness of COVID-19 it is important to consider a broad differential with respiratory illness. Legionella pneumonia on POCUS is consistent with atypical pneumonia descriptions on ultrasound. Point-of-care ultrasound can be used to diagnose atypical pneumonia, specifically caused by Legionella in our case.Conclusion:Legionella is evident on POCUS but is difficult to distinguish from other infections with POCUS alone. One should consider Legionella if POCUS is positive for signs of atypical infection.


  • Open Access

    Probable Locally AcquiredBabesia divergens–Like Infection in Woman, Michigan, USA

    by Erica Herc, Bobbi Pritt, Taylor Huizenga, Richard Douce, Matthew Hysell, Duane Newton, Jennifer Sidge, Eve Losman, John Sherbeck, Daniel R. Kaul

    We report an asplenic patient who was infected with Babesia divergens–like/MO-1. The clinical course was complicated by multiorgan failure that required intubation and dialysis. The patient recovered after an exchange transfusion and antimicrobial drug therapy. Physicians should be alert for additional cases, particularly in asplenic persons.


  • Open Access

    Randomized Trial of Adding Parenteral Acetaminophen to Prochlorperazine and Diphenhydramine to Treat Headache in the Emergency Department

    by Stefan H. Meyering, Ryan W. Stringer, Matthew K. Hysell

    Introduction: Headaches represent over 3 million Emergency Department visits per year comprising 2.4 percent of all ED visits. Headaches are thought to be one of the three most common complaints of patient presentations to EDs across the country. There are many proposed methods and clinical guidelines of treating acute headache presentations however data on intravenous acetaminophen usage in these settings are lacking. Objectives: The study attempts to determine the efficacy of IV Acetaminophen as an adjunct to a standard therapy for the treatment of patients who present to the emergency department with a chief complaint of “headache” or variants thereof. Design: Randomized, double-blind, placebo-controlled trial. Institutional IRB approval was obtained prior to implementation. Setting: Academic Community Hospital. Patients: Key elements of eligibility included adults ages 18-65 who had no mental or physical hindrances to pain assessment or to receiving acetaminophen. Exclusion criteria included those who had received total cumulative dose of acetaminophen >2600mg within past 24 hours, documented or suspected pregnancy, dementia, psychosis, liver cirrhosis, hemodynamic instability or other medical conditions prohibiting acetaminophen use. Ability to understand informed consent was necessary. Interventions: All patients received prochlorperazine, diphenhydramine, 1000ml 0.9% normal saline IV, and were randomized to receive either parenteral acetaminophen (1000mg/100ml) or 100ml of 0.9% NS as control in the placebo group. Main outcome measures: Subjective pain scores rated on a 1-10 Visual Assessment Scale were assessed repeatedly at 30 minute intervals. Length of stay and time to disposition were also noted. The incidence of rescue medications required outside of the initial regimen was also noted, with particular attention to narcotic utilization. Results: Of the (n=45) patients who received IV acetaminophen, 36 reported a statistically significant decrease by pain score of 2 or greater from presentation at the 90 minute mark. Of the (n=45) patients who received placebo, 25 reported a statistically significant decrease by pain score reporting from presentation at the 90 minute mark. (p 0.01, >95% CI). For the acetaminophen group the initial mean VAS pain score was 8.7, for the placebo group 8.6. At 90 minutes 2.2 for Acetaminophen, 4.0 for placebo group. (p99% CI). Length of stay was decreased a mean 36.6 minutes in the Acetaminophen group. 17 patients in the IV acetaminophen and 24 patients in the placebo group received rescue medications, with 18% less in the acetaminophen group requiring narcotics (p 0.01, CI >95). Conclusion: In Emergency Department patients with acute headache, IV Acetaminophen when used as an adjunct to prochlorperazine and diphenhydramine resulted in increased pain reduction, decreased length of stay and less rescue medications utilized including narcotics when compared to treatment with prochlorperazine and diphenhydramine alone.